The Journal of Practical Medicine >
Interpretation of 《Global consensus on multidisciplinary diagnostic criteria for urinary tract infections》
Received date: 2025-05-26
Online published: 2025-09-25
The clinical diagnosis and treatment of urinary tract infection has long faced the challenges of insufficient standardization of diagnosis and treatment pathways， irrational use of antimicrobial drugs and high recurrence rate. How to optimize the hierarchical diagnosis and treatment pathway of urinary tract infection， standardize the use of antimicrobial drugs， and reduce the recurrence rate have always been the focus of clinical attention. There is significant heterogeneity in the existing diagnostic criteria for urinary tract infection， which seriously affects the comparability and evidence integration of clinical and research studies. In order to solve the above problems， a consensus on global multidisciplinary diagnostic criteria for urinary tract infection has been formed by international multidisciplinary experts after three rounds of Delphi method. Breaking through the traditional classification framework， the consensus innovatively established a four-dimensional quantitative scoring system including local symptoms and signs， systemic inflammatory response， quantitative analysis of pyuria and urine culture results， and established a hierarchical standard for stepwise urinary tract diagnosis according to the scoring threshold. Based on the key citations related to the consensus， this paper interprets in detail the basis for the selection of core indicators and the establishment of thresholds for the diagnosis of urinary tract infection in the consensus， and focuses on the key issues and implementation paths of the consensus in localization practice. This consensus provides a unified standard for standardizing the clinical diagnosis and treatment of urinary tract infection， improving the homogeneity of clinical research through standardized diagnostic processes， and promoting the standardization of UTI drug research and development and the rational use of antibiotics and precision.
Guofen LIANG , Zhenhua YANG , Yibo WANG , Kaiyu HE , La ZHANG , Xusheng LIU , Yueyu GU , Xindong QIN , Guobin SU . Interpretation of 《Global consensus on multidisciplinary diagnostic criteria for urinary tract infections》[J]. The Journal of Practical Medicine, 2025 , 41(18) : 2777 -2785 . DOI: 10.3969/j.issn.1006-5725.2025.18.001
| [1] | YANG X， CHEN H， ZHENG Y， et al. Disease burden and long-term trends of urinary tract infections： A worldwide report ［J］. Front Public Health， 2022， 10： 888205. doi:10.3389/fpubh.2022.888205 |
| [2] | ZI H， LIU M Y， LUO L S， et al. Global burden of benign prostatic hyperplasia， urinary tract infections， urolithiasis， bladder cancer， kidney cancer， and prostate cancer from 1990 to 2021 ［J］. Mil Med Res， 2024， 11（1）： 64. doi:10.1186/s40779-024-00569-w |
| [3] | ZENG Z， ZHAN J， ZHANG K， et al. Global， regional， and national burden of urinary tract infections from 1990 to 2019： An analysis of the global burden of disease study 2019 ［J］. World J Urol， 2022， 40（3）： 755-763. doi:10.1007/s00345-021-03913-0 |
| [4] | WANG R， LASALA C. Role of antibiotic resistance in urinary tract infection management： A cost-effectiveness analysis ［J］. Am J Obstet Gynecol， 2021， 225（5）： 550.e1-550.e10. doi:10.1016/j.ajog.2021.08.014 |
| [5] | FROMER D， KHULLAR V， WAGENLEHNER F. Advances in the Management of Acute and Recurrent Urinary Tract Infections Caused by Resistant Pathogens-What′s Next？ ［J］. Eur Med J， 2022： 23-29. doi:10.33590/emj/10081330 |
| [6] | BILSEN M P， JONGENEEL R M H， SCHNEEBERGER C， et al. Definitions of Urinary Tract Infection in Current Research： A Systematic Review ［J］. Open Forum Infect Dis， 2023， 10（7）： ofad332. doi:10.1093/ofid/ofad332 |
| [7] | EUROPEAN ASSOCIATION OF UROLOGY. EAU Guidelines on Urological Infections ［EB/OL］. （2025-03） ［2025-05-08］.. |
| [8] | 黄健，张旭. 中国泌尿外科和男科疾病诊断治疗指南： 2022 版 ［M］. 北京： 科学出版社， 2022：636-649. |
| [9] | ANGER J， LEE U， ACKERMAN A L， et al. Recurrent Uncomplicated Urinary Tract Infections in Women： AUA/CUA/SUFU Guideline ［J］. J Urol， 2019， 202（2）： 282-289. doi:10.1097/ju.0000000000000296 |
| [10] | AGENCY E M. Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections-Revision 3 ［EB/OL］. （2022-12-01） ［2025-05-08］. . |
| [11] | FOOD AND DRUG ADMINISTRATION US. Complicated Urinary Tract Infections： Developing Drugs for Treatment ［EB/OL］. （2018-06） ［2025-05-05］.. |
| [12] | FOOD AND DRUG ADMINISTRATION US. Uncomplicated Urinary Tract Infections： Developing Drugs for Treatment Guidance for Industry ［EB/OL］. （2019-08） ［2025-05-08］. |
| [13] | 国家药品监督管理局药品审评中心. 复杂性尿路感染抗菌药物临床试验技术指导原则 ［EB/OL］. （2020-12-31） ［2025-05-08］.. |
| [14] | 国家药品监督管理局药品审评中心. 单纯性尿路感染抗菌药物临床试验技术指导原则 ［EB/OL］. （2020-12-31） ［2025-05-08］.. |
| [15] | BILSEN M P， CONROY S P， SCHNEEBERGER C， et al. A reference standard for urinary tract infection research： A multidisciplinary Delphi consensus study ［J］. Lancet Infect Dis， 2024， 24（8）： e513-e521. doi:10.1016/s1473-3099(23)00778-8 |
| [16] | BENT S， NALLAMOTHU B K， SIMEL D L， et al. Does this woman have an acute uncomplicated urinary tract infection？ ［J］. Jama， 2002， 287（20）： 2701-2710. doi:10.1001/jama.287.20.2701 |
| [17] | AMMITZB?LL N， BAU B P J， BUNDGAARD-NIELSEN C， et al. Pre- and postmenopausal women have different core urinary microbiota ［J］. Sci Rep， 2021， 11（1）： 2212. doi:10.1038/s41598-021-81790-8 |
| [18] | TIMM M R， RUSSELL S K， HULTGREN S J. Urinary tract infections： Pathogenesis， host susceptibility and emerging therapeutics ［J］. Nat Rev Microbiol， 2025， 23（2）： 72-86. doi:10.1038/s41579-024-01092-4 |
| [19] | VAN BUUL L W， VREEKEN H L， BRADLEY S F， et al. The Development of a Decision Tool for the Empiric Treatment of Suspected Urinary Tract Infection in Frail Older Adults： A Delphi Consensus Procedure ［J］. J Am Med Dir Assoc， 2018， 19（9）： 757-764. doi:10.1016/j.jamda.2018.05.001 |
| [20] | CLAEYS K C， TRAUTNER B W， LEEKHA S， et al. Optimal Urine Culture Diagnostic Stewardship Practice-Results from an Expert Modified-Delphi Procedure ［J］. Clin Infect Dis， 2022， 75（3）： 382-389. doi:10.1093/cid/ciab987 |
| [21] | NELSON Z， ASLAN A T， BEAHM N P， et al. Guidelines for the Prevention， Diagnosis， and Management of Urinary Tract Infections in Pediatrics and Adults： A WikiGuidelines Group Consensus Statement ［J］. JAMA Netw Open， 2024， 7（11）： e2444495. doi:10.1001/jamanetworkopen.2024.44495 |
| [22] | VAN NIEUWKOOP C， BONTEN T N， VAN'T WOUT J W， et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome： A prospective observational study ［J］. Crit Care， 2010， 14（6）： R206. doi:10.1186/cc9328 |
| [23] | LAWANDI A， OSHIRO M， WARNER S， et al. Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum： Real-World Utilization and Performance Characteristics， 65 U.S. Hospitals， 2008-2017 ［J］. Crit Care Med， 2023， 51（11）： 1527-1537. doi:10.1097/ccm.0000000000005968 |
| [24] | DELLINGER R P， LEVY M M， RHODES A， et al. Surviving sepsis campaign： International guidelines for management of severe sepsis and septic shock： 2012 ［J］. Crit Care Med， 2013， 41（2）： 580-637. |
| [25] | 刘峘， 谢雁鸣， 陈耀龙， 等. 《中医药单用/联用抗生素治疗常见感染性疾病临床实践指南·单纯性下尿路感染》的研制 ［J］. 中国中医基础医学杂志， 2019， 25（10）： 1383-1386. |
| [26] | 邓林林， 张啸， 高仪， 等. miR-216a调控NF-κB信号通路参与脓毒症急性肾损伤的机制 ［J］. 实用医学杂志， 2022， 38（17）： 2133-2137. doi:10.3969/j.issn.1006-5725.2022.17.004 |
| [27] | HOOTON T M， ROBERTS P L， COX M E， STAPLETON A E. Voided midstream urine culture and acute cystitis in premenopausal women ［J］. N Engl J Med， 2013， 369（20）： 1883-1891. doi:10.1056/nejmoa1302186 |
| [28] | LARACY J C， CHAN J L， KODAMA R， et al. Improving Urinary Tract Infection Diagnostics in Oncology： Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients ［J］. Clin Infect Dis， 2025， 80（5）： 969-974. doi:10.1093/cid/ciaf018 |
| [29] | BILSEN M P， AANTJES M J， VAN ANDEL E， et al. Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women ［J］. Clin Infect Dis， 2023， 76（12）： 2070-2076. doi:10.1093/cid/ciad099 |
| [30] | VAN DEN BROEK D， KEULARTS I M， WIELDERS J P， et al. Benefits of the iQ200 automated urine microscopy analyser in routine urinalysis ［J］. Clin Chem Lab Med， 2008， 46（11）： 1635-1640. doi:10.1515/cclm.2008.317 |
| [31] | FLORES-MIRELES A L， WALKER J N， CAPARON M， et al. Urinary tract infections： Epidemiology， mechanisms of infection and treatment options ［J］. Nat Rev Microbiol， 2015， 13（5）： 269-284. doi:10.1038/nrmicro3432 |
| [32] | ARIAS C A， MURRAY B E. The rise of the Enterococcus： Beyond vancomycin resistance ［J］. Nat Rev Microbiol， 2012， 10（4）： 266-278. doi:10.1038/nrmicro2761 |
| [33] | HAYES K， O'HALLORAN F， COTTER L. A review of antibiotic resistance in Group B Streptococcus： The story so far ［J］. Crit Rev Microbiol， 2020， 46（3）： 253-269. doi:10.1080/1040841x.2020.1758626 |
| [34] | LUU T， ALBARILLO F S. Asymptomatic Bacteriuria： Prevalence， Diagnosis， Management， and Current Antimicrobial Stewardship Implementations ［J］. Am J Med， 2022， 135（8）： e236-e244. doi:10.1016/j.amjmed.2022.03.015 |
/
| 〈 |
|
〉 |